Últimos Artículos de Diabetes, Obesity and Metabolism
- Associations of PM2.5 and Its Constituents With the Dynamic and Accelerated Progression of Cardiovascular‐Kidney‐Metabolic Syndrome: The Gold‐Health Cohort
- Postprandial Glucose Spikes in Free‐Living Adults With Normoglycaemia Are Associated With Modifiable Dietary and Temporal Factors: A Real‐World CGM Study
- Are Women Living With Obesity More Responsive to GLP‐1 Receptor Agonists? A Potential Signal From Trial‐Level and Within‐Trial Analyses
- Clinical Implications and Research Progress of Salivary Biomarkers for Endocrine and Metabolic Disorders
- Rates of, Reasons for, and Reactions to Discontinuation of GLP‐1 Receptor Agonists: A Narrative Review
- Associations of Fasting Glucagon and the Glucagon–Alanine Index With Hepatic Steatosis and Liver Stiffness in Japanese Individuals With Type 2 Diabetes
- Correction to “Integrated Proteomic and Phosphoproteomic Profiling Unravels an O‐GlcNAc‐Dependent Mechanism in DGAT1 Inhibition‐Mediated Protection of β‐Cells From Lipotoxicity”
- Comparative Effects of Emerging Lp(a)‐Lowering Agents and PCSK9‐Directed Therapies on Lipoprotein(a): A Network Meta‐Analysis of Randomised Clinical Trials
- Reply to the Letter to the Editor ‘Why a Unified TIR–TITR Equation Still Requires Bounded Calibration and Endpoint Anchoring’
- Association of Post‐Oral Glucose Tolerance Test Hypoglycaemia With Clinical Features, Incident Diabetes and Mortality in the Di@bet.es Cohort
- Multi‐Parametric Magnetic Resonance Imaging to Assess Empagliflozin Effect on the Kidneys in People With Type 2 Diabetes Mellitus: A Pilot Clinical Trial
- Projecting the Macroeconomic Burden of Type 2 Diabetes Mellitus Attributable to High Body‐Mass Index in Southeast Asia: A Bayesian Productivity‐Adjusted Life Years Approach Based on Global Burden of Diseases 2023
- Molecular Signature of Prediabetes With High‐Risk of Diabetes Revealed by Deep Plasma Proteome
- Glucagon‐Like Peptide‐1 Based Therapies and the Risk of Severe Gastrointestinal Motility Adverse Events: A Cohort Study
- Glucagon‐Like Peptide‐1 Receptor Agonists and Risk of Parkinson's Disease in Patients With Obesity and Without Type 2 Diabetes
- Trends in Second‐Line Initiations and Treatment Outcomes Across Age and Frailty Groups in People With Type 2 Diabetes: UK Population‐Based Study, 2019–2024
- Impact of User Responses to Smart MDI Notifications: Insights From a Longitudinal Real‐World Study of 2604 Smart MDI System Users
- Intragastric Balloon Treatment Enhances Weight Maintenance Adjunct to Low‐Energy Diet and Group‐Based Cognitive Behavioural Therapy: A Randomized Controlled Trial
- Chronic Kidney Disease in Patients With Type 2 Diabetes Mellitus: A Cross‐Sectional Population‐Based Study
- Semaglutide in Adolescents Living With Obesity: A Real‐World Data Study Exploring Predictors of Treatment Response